X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7669) 7669
Book Chapter (14) 14
Dissertation (6) 6
Magazine Article (5) 5
Publication (4) 4
Conference Proceeding (2) 2
Reference (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ranibizumab (6459) 6459
ophthalmology (5298) 5298
humans (4846) 4846
male (3162) 3162
female (3135) 3135
bevacizumab (2973) 2973
macular degeneration (2820) 2820
aged (2677) 2677
intravitreal injections (2616) 2616
vascular endothelial growth factor a - antagonists & inhibitors (2292) 2292
middle aged (2077) 2077
angiogenesis inhibitors - therapeutic use (1918) 1918
vascular endothelial growth factor (1761) 1761
aged, 80 and over (1652) 1652
tomography, optical coherence (1633) 1633
treatment outcome (1538) 1538
angiogenesis inhibitors - administration & dosage (1407) 1407
retrospective studies (1402) 1402
visual acuity (1382) 1382
fluorescein angiography (1344) 1344
endothelial growth-factor (1289) 1289
eye diseases (1225) 1225
visual acuity - physiology (1220) 1220
age-related macular degeneration (1151) 1151
follow-up studies (1131) 1131
diabetic retinopathy (1105) 1105
genetic structures (1101) 1101
macular degeneration - drug therapy (1069) 1069
choroidal neovascularization (1030) 1030
choroidal neovascularization - drug therapy (952) 952
wet macular degeneration - drug therapy (919) 919
antibodies, monoclonal, humanized (912) 912
photodynamic therapy (895) 895
retina (879) 879
aflibercept (870) 870
optical coherence tomography (848) 848
prospective studies (837) 837
therapy (817) 817
care and treatment (810) 810
antibodies, monoclonal, humanized - therapeutic use (804) 804
macular edema - drug therapy (758) 758
edema (754) 754
sense organs (739) 739
injection (683) 683
verteporfin (682) 682
diabetes (676) 676
neovascularization (671) 671
age (664) 664
physiological aspects (657) 657
adult (653) 653
ranibizumab - therapeutic use (628) 628
patients (627) 627
diabetic macular edema (588) 588
retinopathy (584) 584
ranibizumab - administration & dosage (583) 583
macular edema (569) 569
antibodies, monoclonal, humanized - administration & dosage (558) 558
analysis (553) 553
vegf (545) 545
anti-vegf (543) 543
diabetic retinopathy - drug therapy (539) 539
eye (532) 532
angiogenesis inhibitors - adverse effects (511) 511
abridged index medicus (503) 503
intravitreal injection (493) 493
antibodies, monoclonal - therapeutic use (484) 484
research (483) 483
intravitreal bevacizumab (482) 482
safety (482) 482
medicine & public health (469) 469
drug therapy (464) 464
wet macular degeneration - diagnosis (449) 449
time factors (447) 447
injections (446) 446
efficacy (445) 445
outcomes (440) 440
antibodies, monoclonal - administration & dosage (438) 438
medical imaging (437) 437
prevalence (436) 436
intravitreal ranibizumab (427) 427
wet macular degeneration - physiopathology (424) 424
animals (423) 423
acuity (419) 419
studies (419) 419
risk factors (406) 406
visual acuity - drug effects (400) 400
angiogenesis (395) 395
choroidal neovascularization - etiology (392) 392
choroidal neovascularization - diagnosis (391) 391
pharmacology & pharmacy (389) 389
clinical trials (384) 384
retina - pathology (372) 372
endothelial growth factors (371) 371
fundus oculi (371) 371
recombinant fusion proteins - therapeutic use (359) 359
macular edema - etiology (357) 357
trial (354) 354
visual-acuity (353) 353
vitreous body (348) 348
eyes (339) 339
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7011) 7011
German (330) 330
French (156) 156
Spanish (109) 109
Portuguese (55) 55
Russian (53) 53
Chinese (50) 50
Turkish (43) 43
Czech (24) 24
Korean (22) 22
Japanese (20) 20
Polish (20) 20
Hungarian (6) 6
Danish (4) 4
Norwegian (4) 4
Swedish (4) 4
Italian (3) 3
Slovenian (3) 3
Hebrew (2) 2
Dutch (1) 1
Icelandic (1) 1
Persian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 11/2017, Volume 37, Issue 11, pp. 2035 - 2046
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10011, pp. 2395 - 2403
Journal Article
Acta ophthalmologica (Oxford, England), ISSN 1755-375X, 05/2013, Volume 91, Issue 3, pp. e178 - e183
. Purpose:  Modern therapy of neovascular age‐related macular degeneration consists in intravitreal injections of inhibitors of the vascular endothelial growth... 
photodynamic therapy (Verteporfin®) | age‐related macular degeneration | Ranibizumab (Lucentis®) | choroidal neovascularization | vascular endothelial growth factor | Ranibizumab (Lucentis | photodynamic therapy (Verteporfin | age-related macular degeneration | INTRAVITREAL RANIBIZUMAB | photodynamic therapy (Verteporfin (R)) | DOSING REGIMEN | TRIAL | Ranibizumab (Lucentis (R)) | VERTEPORFIN PLUS RANIBIZUMAB | DISEASE | AMD | OPHTHALMOLOGY | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Prospective Studies | Intravitreal Injections | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Photochemotherapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Microscopy, Acoustic | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Tomography, Optical Coherence | Treatment Outcome | Combined Modality Therapy | Wet Macular Degeneration - diagnosis | Retreatment | Wet Macular Degeneration - drug therapy | Aged | Macular degeneration | Endothelial growth factors | Lasers in surgery | Physiological aspects | Ophthalmology | Neovascularization | Comparative analysis | Cancer | Drug therapy | Photodynamic therapy
Journal Article
Journal Article
Journal Article
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1414 - 1420.e1
Purpose To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the treatment of macular edema secondary to central retinal vein... 
Ophthalmology | TRIAL | BEVACIZUMAB | PHASE-III | SECONDARY | OPHTHALMOLOGY | VEGF TRAP-EYE | RANIBIZUMAB | Dropsy | Edema | Retinal diseases | Consulting services
Journal Article